NS4B（65kDa）抗体说明书 英文名称  Anti-Hepatitis C Virus RNA-directed RNA polymerase

中文名称  NS4B（65kDa）抗体说明书 

别    名 RNA-directed RNA polymerase; p68; RNA dependent RNA polymerase.

产品属性：

浓    度  1mg/1ml

规 格  0.1ml/100μg 0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   HCV

产品类型   一抗  

研究领域    细胞生物 细菌及

蛋白分子量  predicted molecular weight: 65kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from Hepatitis C Virus RNA-directed RNA polymerase

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

NS4B（65kDa）抗体说明书 产品应用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 HCV is a positive, single-stranded RNA virus in the Flaviviridae family. The genome is approximately 10,000 nucleotides and encodes a single polyprotein of about 3,000 amino acids. The polyprotein is processed by host cell and viral proteases into three major structural proteins, and several non-structural proteins necessary for viral replication, of which NS5B is one. NS5B RNA-dependant RNA polymerase is responsible for replication of the hepatitis C viral genome, and is currently a principal target for chemotherapeutic inhibition of HCV replication. Hepatitis C virus (HCV) can cause chronic hepatitis, cirrhosis and hepatocellular carcinoma. At present there is no vaccine effective against HCV. Host membrane insertion occurs after processing by the NS3 protease.

Function : Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Thought to play a role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Could mediate apoptotic pathways through association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptor-induced apoptosis remains controversial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Seric core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. Alters lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage. Core protein induces up-regulation of FAS promoter activity, and thereby probably contributes to the increased triglyceride accumulation in hepatocytes (steatosis).E1 and E2 glycoproteins form a heterodimer that is involved in virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. E1/E2 heterodimer binds to human LDLR, CD81 and SCARB1/SR-BI receptors, but this binding is not sufficient for infection, some additional liver specific cofactors may be needed. The fusion function may possibly be carried by E1. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection.P7 seems to be a heptameric ion channel protein (viroporin) and is inhibited by the antiviral drug amantadine. Also inhibited by long-alkyl-chain iminosugar derivatives. Essential for infectivity.Protease NS2-3 is a cysteine protease responsible for the autocatalytic cleavage of NS2-NS3. Seems to undergo self-inactivation following maturation.NS3 displays three enzymatic activities: serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS* and NS*-NS5B. NS3/NS4A complex also prevents phosphorylation of human IRF3, thus preventing the establishment of dsRNA induced antiviral state. NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand. Cleaves and inhibits the host antiviral protein MAVS.NS4B induces a specific membrane alteration that serves as a scaffold for the virus replication complex. This membrane alteration gives rise to the so-called ER-derived membranous web that contains the replication complex.NS* is a component of the replication complex involved in RNA-binding. Its interaction with Human VAPB may target the viral replication complex to vesicles. Down-regulates viral IRES translation initiation. Mediates interferon resistance, presumably by interacting with and inhibiting human EIF2AK2/PKR. Seems to inhibit apoptosis by interacting with BIN1 and FKBP8. The hyperphosphorylated form of NS* is an inhibitor of viral replication.NS5B is a RNA-dependent RNA polymerase that plays an essential role in the virus replication.Subunit : Core protein is a homomultimer that binds the C-terminal part of E1 and interacts with numerous cellular proteins. Interaction with human STAT1 SH2 domain seems to result in decreased STAT1 phosphorylation, leading to decreased IFN-stimulated gene transcription. In addition to blocking the formation of phosphorylated STAT1, the core protein also promotes ubiquitin-mediated proteasome-dependent degradation of STAT1. Interacts with, and constitutively activates human STAT3. Associates with human LTBR and TNFRSF1A receptors and possibly induces apoptosis. Binds to human SP110 isoform 3/Sp110b, HNRPK, C1QR1, YWHAE, UBE3A/E6AP, DDX3X, APOA2 and RXRA proteins. Interacts with human CREB3 nuclear transcription protein, triggering cell transformation. May interact with human p53. Also binds human cytokeratins KRT8, KRT18, KRT19 and VIM (vimentin). E1 and E2 glycoproteins form a heterodimer that binds to human LDLR, CLDN1, CD81 and SCARB1 receptors. E2 binds and inhibits human EIF2AK2/PKR. Also binds human CD209/DC-SIGN and CLEC4M/DC-SIGNR. p7 forms a homoheptamer in vitro. NS2 forms a homodimer containing a pair of composite active sites at the dimerization interface. NS2 seems to interact with all other non-structural (NS) proteins. NS4A interacts with NS3 serine protease and stabilizes its folding. NS3-NS4A complex is essential for the activation of the latter and allows membrane anchorage of NS3. NS3 interacts with human TANK-binding kinase TBK1 and MAVS. NS4B and NS* form homodimers and seem to interact with all other non-structural (NS) proteins. NS* also interacts with human EIF2AK2/PKR, FKBP8, GRB2, BIN1, PIK3R1, SRCAP, VAPB and with most Src-family kinases. NS5B is a homooligomer and interacts with human VAPB, HNRNPA1 and SEPT6.Subcellular Location : RNA-directed RNA polymerase: Host endoplasmic reticulum membrane; Single-pass type I membrane protein (Potential). Note=Host membrane insertion occurs after processing by the NS3 protease.Post-translational modifications : Specific enzymatic cleavages in vivo yield mature proteins. The structural proteins, core, E1, E2 and p7 are produced by proteolytic processing by host signal peptidases. The core protein is synthesized as a 21 kDa precursor which is retained in the ER membrane through the hydrophobic signal peptide. Cleavage by the signal peptidase releases the 19 kDa mature core protein. The other proteins (p7, NS2-3, NS3, NS4A, NS4B, NS* and NS5B) are cleaved by the viral proteases.Envelope E1 and E2 glycoproteins are highly N-glycosylated.Core protein is phosphorylated by host PKC and PKA.NS* is phosphorylated in a basal form termed p56. p58 is an hyperphosphorylated form of p56. p56 and p58 coexist in the cell in roughly equivalent amounts. Hyperphosphorylation is dependent on the presence of NS4A. Human AKT1, RPS6KB1/p70S6K, MAP2K1/MEK1, MAP2K6/MKK6 and CSNK1A1/CKI-alpha kinases may be responsible for NS* phosphorylation.NS4B is palmitoylated. This modification may play a role in its polymerization or in protein-protein interactions.The N-terminus of a fraction of NS4B molecules seems to be relocated post-translationally from the cytoplasm to the ER lumen, with a 5th transmembrane segment. The C-terminus of NS2 may be lumenal with a fourth transmembrane segment.Core protein is ubiquitinated; mediated by UBE3A and leading to core protein subsequent proteasomal degradation.Similarity : Belongs to the hepacivirus polyprotein family.Contains 1 helicase ATP-binding domain.Contains 1 peptidase C18 domain.Contains 1 peptidase S29 domain.Contains 1 RdRp catalytic domain.机理仍未十分清楚，当HCV在肝细胞内复制引起肝细胞结构和功能改变或干扰肝细胞蛋白合成，可造成肝细胞变性坏死，表明HCV直接损害*，导致起一定作用。但多数学者认为病理反应可能起重要作用，发现肝炎与一样，其组织浸润细胞以CD3+为主，细胞毒T细胞（TC）特异攻击HCV感染的靶细胞，可引起肝细胞损伤。

实验流程：

全、新、优、品、好四大特点：

NS4B（65kDa）抗体说明书 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

正在热销的相关产品：

LBP(Human lipolysaccharide binding protein) ELISA Kit 人脂多糖结合蛋白Multi-class antibodies规格： 48T

Anti-TPSB2 肥大细胞类胰蛋白酶β2Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh Junctophilin 4 连接蛋白JPH4抗体 规格 0.2ml

IL-9 ELISA Kit 大鼠白介素9 96T

Proteasome 20S beta 3 英文名称： 蛋白酶体PSMβ3抗体 0.2ml

C4orf29 英文名称： 4号染色体开放阅读框29抗体 0.2ml

Anti-TPSB2 肥大细胞类胰蛋白酶β2Multi-class antibodies规格： 0.1ml

PSA(Mouse prostate specific antigen) ELISA Kit 小鼠特异性抗原Multi-class antibodies规格： 48T

Anti-CD158b2/KIR2DL3/NKAT2a/FITC 荧光素标记NK细胞抑制性受体2DL3抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh Donkey Anti-human IgG/RBITC 罗丹明标记的驴抗人IgG 规格 0.1ml

HBcAb(IgM) 核心抗体 IgM 96T

MRGX1 英文名称： G蛋白偶联受体MRGX1抗体 0.1ml

AIP1 英文名称： 激活素受体相互作用蛋白1抗体 0.2ml

Anti-CD158b2/KIR2DL3/NKAT2a/FITC 荧光素标记NK细胞抑制性受体2DL3抗体IgGMulti-class antibodies规格： 0.2ml

PLAUR/uPAR(Human Urokinase-type Plasminogen Activator Receptor) ELISA kit 人尿激酶型纤溶酶原激活物受体Multi-class antibodies规格： 48T

Anti-Omgp 少突细胞髓磷脂糖蛋白抗体Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh ID4 DNA结合抑制因子4抗体 规格 0.1ml

LSP(Human liver specific lipoprotein) ELISA Kit 人抗肝特异性脂蛋白抗体 96T

PIM3 英文名称： 丝酸/苏酸蛋白激酶PIM3抗体 0.2ml

C17orf97 英文名称： 17号染色体开放阅读框97抗体 0.2ml

Anti-Omgp 少突细胞髓磷脂糖蛋白抗体Multi-class antibodies规格： 0.1ml

煌绿黄胺嘧啶琼脂250g用于沙门氏的分离培养

ISP培养基 250g 用于链霉菌的培养

改良Camp-BAP氏琼脂基础 Camp-BAP Agar Base,Modified 250 用于弯曲杆菌选择性分离培养(GB标准)

胰蛋白胨大豆肉汤(TSB)250g/瓶用于细菌的增菌、培养incubationmedia胰蛋白胨大豆肉汤(TSB)250g/瓶用于细菌的增菌、培养

HE琼脂平板(9cm) 10个/包 用于沙门氏菌的选择性分离培养

金氏B培养基(KBA)250g用于检测假单胞菌的荧光素

金氏B培养基 King’s B medium 用于铜绿假单菌产荧光色素试验

乳酸菌选择性培养基 Raka-Ray Medium 250克 啤酒中乳酸菌检测和分离培养

标准II号营养琼脂250细菌计数、不含糖，可作血琼脂基础和传代用(MERCK方法)incubationmedia标准II号营养琼脂250细菌计数、不含糖，可作血琼脂基础和传代用(MERCK方法)

胆硫乳琼脂(DHL) 250g 肠道菌选择性培养基，特别是沙门氏菌的选择性分离(GB、SN标

NS4B（65kDa）抗体说明书 BD测试包  规格：  个  用途：  评估预真空蒸汽灭菌器的空气排除（真空）性能。预装配的一次性测试包。灭菌后，解开包裹，取出试...

湿热指示胶带  规格：  18mm*55mm  用途：  将未灭菌与灭菌的物品区分开、蒸汽胶带灭菌后由白色变为黑色。

7.0L密封培养灌  规格：  9.7x13.5x9.5cm  用途：  使用3.5L厌氧产气剂两袋或者2.5L厌氧产气剂三袋；可装42个培养皿。

2.5L密封培养灌  规格：  19.7x13.5x9.5cm  用途：  使用2.5L厌氧产气剂一袋；可装12个培养皿。

技术外包服务:

★NS4B（65kDa）抗体说明书 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。